{"title": "Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines", "author": "Calisha Myers", "url": "https://www.fiercebiotech.com/biotech/crucell-receives-niaid-nih-contract-for-development-of-ebola-and-marburg-vaccines", "hostname": "fiercebiotech.com", "description": "Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines LEIDEN, NETHERLANDS -- (Marketwire) -- 10/03/08 -- Dutch biopharma companyCrucell N.V. (Euronext, Nasdaq: CRXL; Swiss | Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines LEIDEN, NETHERLANDS -- (Marketwire) -- 10/03/08 -- Dutch biopharma companyCrucell N.V. (Euronext, Nasdaq: CRXL; Swiss", "sitename": "FierceBiotech", "date": "2008-10-03", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}